Evan Cunningham
@E_B_Cunningham
Followers
33
Following
39
Media
2
Statuses
32
Joined September 2015
Earlier this afternoon we held our 11th Brett Tindall Memorial Lecture with many thanks to A/Prof @BehzadHajari for presenting his interesting research on #hepC treatment uptake & the challenges to worldwide #hepC elimination. đThanks to all who attended in-person and online.
0
2
9
A team of Kirby researchers have done an in-depth analysis, the largest of its kind, into the effectiveness of a range health interventions to improve hepatitis C care, identifying the best strategies to achieve elimination. @jasongrebely @E_B_Cunningham
https://t.co/OnnUbdu2DD
1
8
9
Great to see our systematic review now published in @LancetGastroHep on effective interventions to enhance #HCV care. Amazing leadership from @E_B_Cunningham @KirbyInstitute in driving forward this massive effort. Thank you to our co-authors and those who contributed data.
New research - Cunningham et al - Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis #nohep #hepC #HCV #LiverTwitter @KirbyInstitute @E_B_Cunningham @jasongrebely
0
10
34
If you missed the presentation from @E_B_Cunningham, remember that it will be online to view within 24 hours #HCV #INHSU2021
@E_B_Cunningham from @KirbyInstitute, covering âInterventions to Enhance Testing and Treatment Uptake for Hepatitis C Infectionâ. This systematic review is part of the evidence underpinning INHSUâs exciting HCV Intervention Toolkit, currently in development- watch this space!
0
2
3
@E_B_Cunningham from @KirbyInstitute, covering âInterventions to Enhance Testing and Treatment Uptake for Hepatitis C Infectionâ. This systematic review is part of the evidence underpinning INHSUâs exciting HCV Intervention Toolkit, currently in development- watch this space!
0
6
8
Do you want to hear about exciting career trajectories? Join Dr Suzi Hudson, @wolfenyc, @ManojStuart and @ShelleyFacente this Friday morning at the #INHSU2021 conference to discuss how you can build on your research experience to meet your career goals.
0
6
7
PhD candidate @valerio_heather will be presenting at today's Progress Toward HCV Elimination parallel session at #INHSU21. Come hear about the progress toward HCV elimination in Australia and where we need to concentrate our efforts to ensure this elimination is equitable.
0
3
10
Dr Alison Marshall's presentation on the willingness among people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate HCV treatment is available on-demand at #INHSU21. Grab your cup of INHSU coffee and give it a watch!
0
3
5
Pleased to share our @ijdrugpolicy editorial highlighting the need for person-centred strategies to address HCV, other infectious diseases, and harms that may relate to drug use. Highlights a special issue with nearly 40 papers on these topics
2
13
44
Proud to be leading this $6.5M @healthgovau grant to scale-up point-of-care Xpert HCV RNA testing in Australia. This game-changing test enables same-visit HCV diagnosis and treatment, facilitating elimination efforts. Thanks to >30 partners, including @Flinders @HepAus.
A $6.5 million investment from @healthgovau will see the Kirby, @Flinders & @HepAus establish a national program to scale up hepatitis C point-of-care testing. This important initiative will help Australia achieve hep C elimination targets. https://t.co/eccWJEL9Nz
2
8
54
Congrats to CanHepC lead researcher Dr Mel Krajden who will be receiving BC's highest honorđď¸for his outstanding work advancing public health policies for #Hepatitis and other viruses! We already knew he was an increadible human being, now it's official! Well deserved! đđ
Congratulations to Dr. Mel Krajden of the BC Centre for Disease Control on being appointed to the Order of British Columbia, the province's highest form of recognition! Join us in celebrating Dr. Krajden for his leadership & contributions to the province! https://t.co/xU8QJ3eMWA
1
5
25
Very proud to announce that @GlobalHep has named Dr Brian Conway a 2020 Elimination Champion!đ He's among 5 other champions selected across theđfor his commitment to making #HCV elimination benefit all of society, including the most vulnerable. âŹď¸ https://t.co/pAxNWsXYx8
0
5
12
#CanHepC investigator Dr Curtis Cooper on the impact of covid-19 on hepatitis C services and challenges ahead as we strive for elimination: @catieinfo #WorldHepatitisDay
thesudburystar.com
0
8
18
Check out our @CanHepCtrainee opinion peice in the @mtlgazette today on the impact of COVID-19 on the battle against hepatitis C @LanieceDelaunay @Hep_Alliance #WHD2020
0
3
9
"We need to stop viral hepatitis and its stigma from ravaging the lives of millions of people" Professor Manal El-Sayed has sent a powerful #WHDRelay message from Cairo, Egypt. Thank you, Manal! Watch her video below and let us know what your #WorldHepatitisDay message is.
0
8
24
See the opinion piece authored by myself and @LanieceDelaunay and all of the @CanHepCtrainee published today in the Montreal Gazette! Let's all work together and commit to #hepatitisC elimination in the era of COVID-19! @canhepc @KirbyInstitute
In recognition of #WHD2020, letâs maintain and strengthen our efforts towards #hepatitisC elimination in the era of #COVID19! See the @CanHepC trainees call for action at the interface of the hepatitis C and COVID-19 pandemics. https://t.co/mt4HCNBzyB
#WorldepatitisDay
0
7
12
Monitoring #HCV adherence using a novel electronic blister pack among recent #PWID receiving #DAA therapy with SOF/VEL in the SIMPLIFY study - great presentation by @E_B_Cunningham @KirbyInstitute #INHSU18 @INHepSU
0
3
4
New: Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis - https://t.co/gdFpwIqo7V
#nohep #hepC #free for #INHSU18 @INHepSU @jasongrebely @BehzadHajari
0
11
12
.@E_B_Cunningham from @KirbyInstitute presenting data which help to understand adherence to #HCV DAA therapy in #PWID in the SIMPLIFY study at #INHSU18 @INHepSU
0
3
4
New systematic review and meta-analysis in @LancetGastroHep demonstrates that response to DAA #HCV therapy is favourable in people with recent drug use and those receiving #OST - Great leadership by @BehzadHajari @KirbyInstitute - #INHSU18 @INHepSU
https://t.co/qBrlVTUwBB
0
12
19